Injection of Lrp6-silenced EO771 cells did not alter mammary tumors (Supplementary Fig. 3e, f), and Lrp6-silenced osteocyte-derived CM did not suppress the antitumor action of osteocytes (Supplementary Fig. 3g, h). This evidence concerns the gene LRP6 and breast cancer.